Next Article in Journal / Special Issue
The Production of the PHAR-QA Competence Framework
Previous Article in Journal / Special Issue
Competence-Based Curricula in the Context of Bologna and EU Higher Education Policy
 
 
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Article

The Implementation of Pharmacy Competence Teaching in Estonia

1
Institute of Pharmacy, University of Tartu, Nooruse 1, 50411 Tartu, Estonia
2
Estonian Pharmacies Association; Vae 16, Laagri, 76401 Harju County, Estonia
*
Author to whom correspondence should be addressed.
Greatly involved in curriculum development
Pharmacy 2017, 5(2), 18; https://doi.org/10.3390/pharmacy5020018
Submission received: 22 January 2017 / Revised: 16 March 2017 / Accepted: 27 March 2017 / Published: 31 March 2017
(This article belongs to the Special Issue Competence Training for Pharmacy)

Abstract

:
Background: The PHAR-QA, “Quality Assurance in European Pharmacy Education and Training”, project has produced the European Pharmacy Competence Framework (EPCF). The aim of this study was to evaluate the existing pharmacy programme at the University of Tartu, using the EPCF. Methods: A qualitative assessment of the pharmacy programme by a convenience sample (n = 14) representing different pharmacy stakeholders in Estonia. EPCF competency levels were determined by using a five-point scale tool adopted from the Dutch competency standards framework. Mean scores of competency levels given by academia and other pharmacy stakeholders were compared. Results: Medical and social sciences, pharmaceutical technology, and pharmacy internship were more frequent subject areas contributing to EPCF competencies. In almost all domains, the competency level was seen higher by academia than by other pharmacy stakeholders. Despite on-board theoretical knowledge, the competency level at graduation could be insufficient for independent professional practice. Other pharmacy stakeholders would improve practical implementation of theoretical knowledge, especially to increase patient care competencies. Conclusions: The EPCF was utilized to evaluate professional competencies of entry-level pharmacists who have completed a traditional pharmacy curriculum. More efficient training methods and involvement of practicing specialists were suggested to reduce the gaps of the existing pharmacy programme. Applicability of competence teaching in Estonia requires more research and collaborative communication within the pharmacy sector.

1. Introduction

1.1. Pharmacy Education and Training in Estonia

The Faculty of Medicine at the University of Tartu (UT), Estonia, provides higher education and several PhD programmes in medicine, dentistry, pharmacy, sport sciences, and physiotherapy [1]. Pharmacists (proviisor in Estonian) study at the UT for five years and graduate with a Masters of Pharmacy (MSc Pharm) (Figure 1). Pharmacists can be owners and managers of community pharmacies, work as responsible pharmacists in the community and hospital pharmacies, or other pharmacy fields (e.g., wholesale companies or in the pharmaceutical industry). Effective as of 2020, the ownership of community pharmacies will be limited to the pharmacy profession (more than 50 per cent of the shares have to belong to pharmacists). Currently, the majority of community pharmacies have joined different pharmacy chains and mainly traditional services (e.g., dispensing and counselling of the use of prescription and non-prescription medicines) have been provided. In addition, different extended services (e.g., diagnostic clinical tests) have developed [2]. Assistant pharmacists (farmatseut in Estonian) study at Tallinn Healthcare College for three years and are mainly employed in community pharmacies after graduation [3]. Specialists with a diploma of assistant pharmacist who want to continue their education and become pharmacists have to pass the full five-year programme at UT. All practicing pharmacists and assistant pharmacists have to be registered at the corresponding professional register and have to participate in the continuing professional development (CPD) courses for at least 40 h over two years [4] (Figure 1).
The pharmacy programme at UT is designed as medical subject-based and pharmaceutical product-oriented, following the sectorial profession model and the EU directives [5,6]. The curriculum is organized as a course based on five years of integrated bachelor and master training (300 ECTS). The existing pharmacy programme is the basis for recognition of professional qualification. Currently the pharmacy curriculum is available only in Estonian and does not offer specialization. However, international students could participate in research work or take single courses based on individual learning and examination [7].
The pharmacy programme is constantly reviewed and modified. The proportion of in-class lectures has decreased, while independent work has increased; problem-based and research-based training have been introduced in some subjects. The proportion of chemistry-based subjects has decreased and the amount of pharmaceutical technology and medical subjects has increased. A large proportion of medical subjects in the pharmacy programme was intended to prepare future pharmacists for more efficient collaboration in health care teams. During the last ten years, interdisciplinary subjects such as pharmacoeconomics and pharmacoepidemiology, biotechnology, genetics, and bioethics have been integrated into the programme. The patient care concept has been introduced by subjects such as primary care medicine, laboratory medicine, clinical microbiology, clinical pharmacology, and clinical pharmacy (the last subject was added in 2017) (see Appendix A). A comparison of the pharmacy programme of the UT with respective pharmacy curricula in the EU is presented in Table 1 [8].
In the Pharmacy programme, four subject groups—drug analysis (chemistry subjects and pharmacognosy), pharmaceutical technology, medical, and social sciences—have been identified (Table 2). Continuity of the subject areas is organized by the system of pre-subjects: subjects placed in the earlier years of training are pre-requisite subjects for the following, and more specialized, subjects (see Appendix A).

1.2. How to Achieve Competency Based Pharmacy Education in Estonia?

Current pharmacy programme at the UT is compiled using a traditional subject and course-based system. Identification and description of the “flow chart” of subject areas in the pharmacy programme could be seen as a start to describe the curriculum by competencies. The next possible step could be the connection of subject areas with particular entry-level pharmacist professional competencies in the future.
Another possibility to collect valuable information for development of pharmacy training could be to use professional guidelines, e.g., “Community pharmacy service quality guidelines” [9] and “Estonian hospital pharmacy good practices” [10] that were developed and implemented in 2012 and 2015, respectively. Both guidelines shape the expected quality of pharmacy practice in community and hospital setting in Estonia. Community pharmacy guidelines list the indicators that every community pharmacy could use for self-assessment of its pharmacy operation and service provisions. Guideline based self-assessment reports have showed community pharmacists to have higher confidence about providing traditional rather than extended services. Patient-centred counselling of medicines and the provision of extended services are impeded by the shortage of professional personnel, the lack of private consultation possibilities at pharmacies, lack of motivation towards treatment, and use of medicines among patients, as well as by the insufficient professional competency of community pharmacists [2].
Changes within pharmacy profession competencies include moving from product- to patient-oriented knowledge and skills. More attention has to be paid to patient-centred pharmaceutical care services. There are several existing frameworks for evaluating changes in the performance and competence of practicing pharmacists [11,12,13,14,15,16]. For entry-level pharmacists, competency guidelines based on curriculum outcomes have been developed in Canada, Australia, and the UK [17,18,19]. The European Pharmacy Competence Framework (EPCF) has been produced within the project PHAR-QA, “Quality Assurance in European Pharmacy Education and Training”, as a new assessment tool for competency-based pharmacy training in Europe [20].
The aim of this study was to evaluate the existing pharmacy programme at the UT by using the EPCF:
-
to construct a curriculum mapping matrix;
-
to assess the pharmacy curriculum outcome based competency level, and
-
to identify the pharmacy curriculum gaps and evaluate the expediency of the EPCF as a curriculum mapping tool.

2. Materials and Methods

2.1. PHAR-QA Framework

The EPCF was produced by EU project PHAR-QA, “Quality Assurance in European Pharmacy Education and Training”. Developed tool includes personal and patient care competences presented in 11 domains and 50 particularly defined competences (Appendix B). The tool has been validated in a two-round Delphi survey by more than 2000 representatives of different pharmacy stakeholders in Europe [21,22]. For the implementation of the EPCF, it was important to learn its usability as a guideline for evaluation and development of pharmacy curricula in the EU. UT, Institute of Pharmacy, acted as a partner in the PHAR-QA project, and volunteered to pilot the tool for the evaluation of the pharmacy programme.

2.2. Study Design and Sample

The initial study design was developed and proposed by Prof. Andries Koster, University of Utrecht, Utrecht, Netherlands [23]. Among pharmacy schools piloting the EPCF, the following study structure was agreed upon:
-
intended (existing) curriculum mapping: matrix construction of 50 EPCF competences and curriculum elements;
-
evaluation of expected competency level at the graduation of first-degree curriculum (MSc degree); and
-
identification of curriculum gaps.
A qualitative assessment of the pharmacy programme was performed and a convenience sample of different pharmacy stakeholders was involved: academia (teaching staff at the Institute of Pharmacy), wholesale and retail sale of medicines, hospital pharmacy, representatives of pharmaceutical industry, and other fields (e.g., State Agency of Medicines).
Instead of studying pharmacy students’ perception about the competency-based curriculum, the decision was to involve recently graduated pharmacists who could analyse the pharmacy programme from the point of view of both students and pharmacists. Fourteen evaluators (seven from academia and seven from other pharmacy fields) participated in the assessment. Six of the respondents had graduated recently (1–5 years ago) and eight were experienced specialists.

2.3. Data Analysis

As some of the EPCF competences were supported by more than one pharmacy programme subject, evaluators decided to use different types of curriculum elements (subjects, subject areas, and full programme) in the mapping exercise. The subject area was defined by using previously-determined subject groups (Table 2). In the evaluation, all pharmacy programme subjects (obligatory and elective) were used. Detailed description of the pharmacy programme at UT is presented in Appendix A.
Based on the outcomes of curriculum elements and evaluators’ own practical experience, the competency levels were identified according to the personal and patient care competences listed in EPCF. A five-point scale tool, adopted from the Dutch competency standards framework [23] and based on the increase of professional independence, was used as follows:
-
1: Theoretical education; LEVEL OF INDEPENDENCE 1;
-
2: Theoretical education and practical skills; LEVEL OF INDEPENDENCE 2;
-
3: Ability to use theoretical knowledge and practical skills in learning situations; LEVEL OF INDEPENDENCE 3;
-
4: Ability to use theoretical knowledge and practical skills in authentic learning situations (classroom and during pharmacy internship); LEVEL OF INDEPENDENCE 4;
-
5: Ability to use theoretical knowledge and practical skills in practice; LEVEL OF INDEPENDENCE.
The required competency level for recent pharmacy programme graduates at UT could start with a professional independence level 3 and higher. The mean values for 11 competence domains based on the described five-point scale assessment tool were calculated and the results of academia and other pharmacy stakeholders were compared.
In this article the term “competence” is used to describe knowledge and skills—standards—needed to reach professional performance. The term “competency” describes behaviour and commitment in achieving competences.

3. Results

3.1. Construction of Curriculum Mapping Matrix

Table 3 shows developed matrix based on the 11 competence domains of the EPCF and the pharmacy programme elements. EPCF personal competences were mostly covered by the full programme with emphasis on some subject areas. The EPCF patient care competences were supported by specific subject areas or specific subjects, and the number of subjects covering these competences increased with study years. The existing pharmacy programme included subjects and subject areas in logical order and, thus, supported the generation of professional competency. More frequent subject areas for reaching the 50 EPCF competences were medical and social sciences, pharmaceutical technology, and pharmacy internship. Medical and social sciences both contributed to 40% and pharmacy internship to 30% of the listed competences. Elective subjects covered personal as well as patient care competences. In some cases, the competence was supported mostly by the elective courses, e.g., the domain “patient education”.
Not all of the EPCF competences were covered with the pharmacy programme subjects. For example: the business and entrepreneurship competences (“ability to identify the need for new services” and “ability to understand a business environment and develop entrepreneurship”) have not been covered by any of the curriculum subjects. The competences about drug registration and marketing; supply chain of medicines, and public health issues have been very briefly taught in different obligatory and elective subjects.

3.2. Competencies of Entry-Level Pharmacists

In both academia and other pharmacy stakeholders’ groups the level of personal competencies was assessed higher than patient care competencies (Table 3). In almost all domains, the competency level was perceived to be at a higher level by academia than the pharmacy sector representatives. The latter evaluated personal and patient care competency level as three on the five-point scale. The academia group rated personal competency level higher (four on a five-point scale), but agreed with the pharmacy sector group on patient care competency level. The two groups disagreed the most on the level of personal competencies in the domain “research and industrial pharmacy”. Considerable variations were identified in patient care competency levels in two domains: “drug dose and formulation” and “provision of information and service”.

3.3. Curriculum Gaps

Both groups of evaluators described more and less positive aspects of the pharmacy programme. An expansive education was expected to support critical thinking and logical problem solving, large proportion of medical subjects, and the involvement of practicing specialists from different pharmacy fields were emphasized as good basis for contemporary higher education.
Representatives of different pharmacy sectors addressed several issues in the pharmacy programme organization and training methods:
-
increase collaboration between different healthcare professions; more integrated training and common courses with medical students;
-
support more patient care competencies linking the pharmacy programme with practice on different fields of pharmacy starting already from the first years of studies;
-
support the reflection and practical implementation of theoretical knowledge, more broad use of problem-based learning in different subjects;
-
introduce business and entrepreneurship subjects to the pharmacy programme as from 2020, pharmacy ownership will be limited only by pharmacy profession in Estonia;
-
develop more detailed requirements for pharmacy students and for internship supervisors at community and hospital pharmacies as pharmacy internship plays very important role in implementing of professional competencies.

3.4. Usability of EPCF in Curriculum Mapping and Competency Level Evaluation

The EPCF was utilized to identify competencies that have not been covered by the existing pharmacy programme or competencies that were not sufficiently supported by existing subjects. As the EPCF has been designed with a focus on professional competencies required in community pharmacy, this could, to some extent, impede using this type of tool for evaluation of the curriculum without specialization. This kind of training focuses on providing as broad professional knowledge as possible and does not concentrate in detail only on patient care competencies. For competency level evaluation, a proposal was made to use the five-step Dutch competency standards framework because Miller’s ‘pyramid’ (knows, knows how, shows how, and does) does not provide a detailed description of professional knowledge and independence of pharmacists on different competency levels. To address more country-specific needs, other evaluation methods could be considered or developed in future.

4. Discussion

This was the first time the use a competency-based model has been applied for the evaluation of the pharmacy programme at the UT. The assessment provided important information and it is in line with the recommendations presented by an international accreditation team of the Medicine Study Programme Group at UT in 2014 [24]. Both evaluations stressed the need for integrated and novel training methods, for self-reflection and analysis of acquired knowledge by students and for more frequent collaboration between practicing specialists so theoretical knowledge could be implemented into practice better.
Gradual implementation of medical subjects to the pharmacy programme was planned to increase professional competency of pharmacists as healthcare professionals. Based on the EPCF evaluation, the medical subjects of the existing pharmacy programme might not provide sufficient support to patient care competencies in terms of practical usability. However, the description of professional competencies for pharmacists and assistant pharmacists had been missing for the past two decades in Estonia and this situation was not conductive to providing practice-linked training. In November 2016, the occupational qualification standards for pharmacists and assistant pharmacists were approved in Estonia [25]. The standards enable clear identification of professional roles within the pharmacy profession and provide detailed descriptions of required competencies. This kind of supporting information will be vital for the advancement of pharmacy education in Estonia in future.
Representatives of the academia and other pharmacy stakeholders gave different scores to EPCF personal and patient care competencies level. Level of personal competencies was evaluated with a higher score than level of patient care competencies. As many of personal competences were seen as covered by the full pharmacy programme, the level of evaluated competencies could be more speculative than in the case of patient care competences where specific subjects were listed to support the particular competence.
Although the common agreement was to analyse the existing pharmacy programme, the competency evaluation could be conducted on various levels: for academia as knowledge-delivered level and for other pharmacy stakeholders as mix of perceived (viewpoint of students) and realized (viewpoint of practicing specialists and employers) levels. For academia, the evaluation was based on assumptions about the use of theoretical knowledge in practice. Representatives of other pharmacy sectors were expecting not only theoretically competent specialists, but somebody who could perform and fluently use acquired professional knowledge in their specific field of pharmacy. The delivery of diverse educational content might be the reason for surprisingly large score variations given by academia and other pharmacy stakeholders to patient care competencies: “drug dose and formulation” and “provision of information and service”. Both domains describe core competencies of the pharmacy profession and have to be covered by any type of pharmacy curriculum. However, training methods play an important role in the use of acquired knowledge. Case- and problem-based learning could assure more practical use of theoretical knowledge and help future specialists to settle into working life more easily. Pharmacists planning to work in particular areas could have the possibility of constructing a description or list of competencies that are of importance and could assist in their professional performance. This type of differential approach is described in the National Competency Standards Framework for Pharmacists in Australia and would help to elucidate what competencies have to be developed more at CPD courses [19].
The development and implementation of a competency based pharmacy curriculum is a long process and requires common understanding of the higher education institution, other partners in the pharmacy sector and governmental institutions about the demand for considerable change in pharmacy education.
The UT has recently paid a lot of attention to the improvement of teaching and learning quality and published principles of Good Practice of Learning and Good Practice of Teaching, which is a part of the university's good practices. The new practice stimulates students and university staff members to be motivated to teach and learn. In addition, students are encouraged to self-reflect and analyse their studies, which is very important feedback in outcome-oriented professional education [26,27]. Good Practice of Teaching encourages development of teaching communities and emphasises the following principles: excellent teaching is learning centred, based on a scientific way of thinking and cooperation, supports creativity and entrepreneurship, leads to self-analysis, and supports individual development and links learning to real life [27].
In addition to the redesigning of the teaching and learning practices, it is necessary to assure conditions for the provision of competency based clinical practice. The development of professional competency is a continuous process involving both under- and post-graduate education.
Limitations
For all evaluators, curriculum development was not their field of expertise. In the future, it would be necessary to consult with curriculum development specialists and education scientists at the UT about curriculum organization and novel training methods. Additionally, more pharmacy stakeholders have to be involved in discussions and the decision-making process in order to identify the needs for pharmacy competence teaching in Estonia.

5. Conclusions

The EPCF-based mapping exercise of the pharmacy programme at UT provided useful information regarding professional competencies of entry-level pharmacists who have completed traditional pharmacy curriculum. Most of the EPCF competence domains were covered by subjects, subject areas, or the full pharmacy programme. However, to assure independent and responsible patient-centred professional practice, personal and patient care competency levels at graduation could be higher. Representatives of academia and other pharmacy stakeholders concluded that the existing pharmacy programme is designed to provide broad theoretical knowledge, but more efficient training methods should be implemented and practicing specialists from different fields of pharmacy should participate in the teaching process to link theory with practice more efficiently.
Additional research and continuous collaboration within the pharmacy sector is important in order to understand what would the most applicable way to move towards competency-based pharmacy training in Estonia.

Acknowledgments

The authors would like to thank representatives of the UT: Karin Kogermann, Urve Paaver, Ivo Laidmäe, Andres Lust, and Janne Sepp, and other pharmacy stakeholders, Timo Danilov, Kertu Margus, Marko Tähnas, Liisa-Kai Pedosk, Anne-Greete Raadom, and Marika Saar for their contribution to the curriculum mapping exercise.

Author Contributions

K.S. and D.V. performed the experiments; D.V. analysed the data and wrote the initial version of the paper. K.S. and A.R. provided constructive criticism of the manuscript.

Conflicts of Interest

The authors declare no conflict of interest.

Appendix A

Table A1. Content of the curriculum Pharmacy for entrants at the University of Tartu, Estonia, of 2016/2017.
Table A1. Content of the curriculum Pharmacy for entrants at the University of Tartu, Estonia, of 2016/2017.
Pharmacy (300 ECTS)
1. Compulsory subjects (224 ECTS)
1.1 First course compulsory subjects (51 ECTS)
ARFA.02.099Analytical Chemistry12ECTS
ARAN.01.034Anatomy5ECTS
ARFS.01.023Biophysics4ECTS
LOKT.00.004General and Inorganic Chemistry6ECTS
ARFS.01.063Human Physiology10ECTS
ARFA.01.071Introduction and History of Pharmacy3ECTS
FLKE.05.009Latin in Pharmacy3ECTS
ARMB.00.001Medical Microbiology6ECTS
ARFA.02.098Pharmaceutical Terminology3ECTS
ARFA.01.072Pharmacognosy I3ECTS
MTMS.01.085Statistical Analysis4ECTS
1.2 Second course compulsory subjects (52 ECTS)
ARFA.02.099Analytical Chemistry12ECTS
ARFA.02.108Bioethics4ECTS
ARBK.01.042Bioorganic Chemistry5ECTS
ARMB.01.053Clinical Microbiology2ECTS
ARMP.01.030Genetics3ECTS
ARFS.01.063Human Physiology10ECTS
ARBK.01.043Medical Biochemistry5ECTS
ARMP.03.031Pathophysiology6ECTS
ARFA.02.109Pharmaceutical Chemistry I9ECTS
ARFA.02.103Pharmaceutical Excipients5ECTS
ARPO.00.020Primary Care Medicine5ECTS
1.3 Third course compulsory subjects (52 ECTS)
ARMP.03.035Biotechnology3ECTS
ARSK.03.017Introduction to the Laboratory Medicine2ECTS
ARFA.02.112Pharmaceutical Chemistry II8ECTS
ARFA.02.113Pharmaceutical Technology22ECTS
ARFA.01.105Pharmacognosy II7ECTS
ARFA.01.077Pharmacognosy III4ECTS
ARFR.02.051Pharmacology11ECTS
1.4 Fourth course compulsory subjects (51 ECTS)
ARFA.02.144Biopharmaceutics5ECTS
ARFR.03.018Clinical Pharmacology2ECTS
ARFA.01.104Clinical Pharmacy3ECTS
ARFR.02.034Drug Toxicology3ECTS
ARKI.01.004First Aid3ECTS
ARMP.02.016Immunology2ECTS
ARFA.02.123Metabolism of Active Substances3ECTS
ARFA.02.113Pharmaceutical Technology22ECTS
ARFA.01.059Pharmacoepidemiology and Pharmacoeconomics3ECTS
ARFR.02.052Pharmacotherapy5ECTS
ARFA.02.122Physical Pharmacy6ECTS
ARFA.01.082Social Pharmacy and Drug Safety11ECTS
1.5 Fifth course (18 ECTS)
ARFA.02.040Designing of Research Work1ECTS
ARFA.02.044Pharmaceutical Commodities4ECTS
ARFA.00.057Research Work6ECTS
orARFS.01.076Diploma Work6ECTS
orARBK.01.048Research Work6ECTS
orARMB.01.059Diploma Work6ECTS
orARFR.02.061Diploma Work6ECTS
orARAN.00.040Research Project6ECTS
seminar of research (7 ECTS) or
ARFA.02.117Research Seminar on Pharmaceutical Chemistry7ECTS
ARFA.02.116Research Seminar on Pharmaceutical Technology7ECTS
ARFA.01.078Research Seminar on Pharmacognosy7ECTS
ARFA.01.080Research Seminar on Social Pharmacy7ECTS
ARFA.01.096Research Seminars on Clinical Pharmacy7ECTS
ARFA.02.118Research Seminars on History of Pharmacy7ECTS
ARFS.01.075Research Workshop of Physiology7ECTS
ARAN.02.027Seminar on Histology7ECTS
ARBK.01.047Seminars of Research in Medical Biochemistry7ECTS
ARMB.01.060Seminars of Research in Medical Microbiology7ECTS
ARFR.02.060Seminars of Research in Pharmacology7ECTS
2. Elective courses (22 ECTS)
2.1 First course elective subjects (6 ECTS)
FLKE.03.151Estonian for Students of Medicine, on the Basis of Russian, Level B1 >B23ECTS
ARFA.02.080Exercises and Problems in Pharmaceutical Analysis1ECTS
ARLA.01.034Foetal and Neonatal Physiology and Behaviour, Breastfeeding2ECTS
ARSK.00.009Gerontology. Introduction (web-based)3ECTS
FLFI.00.002Introduction to Philosophy2ECTS
ARFA.01.106Pharmacist in pharmacy system2ECTS
ARTH.04.023Prevention of HIV/AIDS and HIV Positive Patient2ECTS
ARTH.04.022Principles of Sexuality Education3ECTS
ARFA.02.145Seminars in Pharmaceutical Sciences I1ECTS
ARTH.04.024Smoking and Health1ECTS
LOKT.01.017Solutions2ECTS
ARSI.01.015Spectacles, Contact Lenses and Refractive Surgery1ECTS
ARLA.01.033Why and to Which Factors We are Allergic?2ECTS
2.2 Second course elective subjects (5 ECTS)
ARBK.01.021Basic Knowledge for the Research in Medical Biochemistry (I)2ECTS
ARMP.03.019Basic Research in Pathophysiology I6ECTS
ARMP.03.020Basic Research in Pathophysiology II6ECTS
ARFA.02.080Exercises and Problems in Pharmaceutical Analysis1ECTS
ARLA.01.034Foetal and Neonatal Physiology and Behaviour, Breastfeeding2ECTS
ARSK.00.009Gerontology. Introduction (web-based)3ECTS
ARFA.02.138Interdisciplinary Seminars in Pharmacy2ECTS
ARFS.01.005Neurophysiology of Pain2ECTS
ARFA.01.106Pharmacist in pharmacy system2ECTS
ARTH.04.023Prevention of HIV/AIDS and HIV Positive Patient2ECTS
ARTH.04.022Principles of Sexuality Education3ECTS
ARFA.02.019Propaedeutical Training3ECTS
ARFA.02.081Radiopharmaceuticals1ECTS
ARFA.02.145Seminars in Pharmaceutical Sciences I1ECTS
ARTH.04.024Smoking and Health1ECTS
ARSI.01.015Spectacles, Contact Lenses and Refractive Surgery1ECTS
ARFA.02.128Student Research in Pharmacy I3ECTS
ARFA.02.135Student Research in Pharmacy II6ECTS
ARLA.01.033Why and to Which Factors We are Allergic?2ECTS
2.3 Third course elective subjects (5 ECTS)
ARBK.01.035Basic Knowledge for the Research in Medical Biochemistry (II)5ECTS
ARMP.03.019Basic Research in Pathophysiology I6ECTS
ARMP.03.020Basic Research in Pathophysiology II6ECTS
ARFA.02.124Chemistry of Vitamins2ECTS
ARTH.01.080Environmental and Occupational Toxicology3ECTS
ARFA.02.080Exercises and Problems in Pharmaceutical Analysis1ECTS
ARLA.01.034Foetal and Neonatal Physiology and Behaviour, Breastfeeding2ECTS
ARSK.00.009Gerontology. Introduction (web-based)3ECTS
ARFA.02.126Granulation and Tableting Technology2ECTS
ARTH.04.018Health Promotion2ECTS
ARFA.02.138Interdisciplinary Seminars in Pharmacy2ECTS
ARFS.01.005Neurophysiology of Pain2ECTS
ARMP.03.025Pathophysiology of Stress1.5ECTS
ARFA.01.106Pharmacist in pharmacy system2ECTS
ARTH.04.023Prevention of HIV/AIDS and HIV Positive Patient2ECTS
ARTH.04.022Principles of Sexuality Education3ECTS
ARFA.02.081Radiopharmaceuticals1ECTS
ARFA.02.145Seminars in Pharmaceutical Sciences I1ECTS
ARTH.04.024Smoking and Health1ECTS
ARSI.01.015Spectacles, Contact Lenses and Refractive Surgery1ECTS
ARFA.02.128Student Research in Pharmacy I3ECTS
ARFA.02.135Student Research in Pharmacy II6ECTS
ARFA.02.130Student Research in Pharmacy III6ECTS
ARFA.02.133Student Research in Pharmacy IV6ECTS
ARFA.02.015Synthesis of Active Substances2ECTS
ARFA.02.140Vibrational Spectroscopy- Different Applications in Pharmaceutical Drug Development1ECTS
ARTH.01.014Water and Health2ECTS
ARLA.01.033Why and to Which Factors We are Allergic?2ECTS
ARTH.01.040Work Stress and Health2ECTS
2.4 Fourth course elective subjects (6 ECTS)
AROT.00.030Andragogy and Higher Education3ECTS
AROT.00.033Applications of Developmental Psychology in Nursing3ECTS
ARMP.03.019Basic Research in Pathophysiology I6ECTS
ARMP.03.020Basic Research in Pathophysiology II6ECTS
ARTH.01.080Environmental and Occupational Toxicology3ECTS
ARFA.02.080Exercises and Problems in Pharmaceutical Analysis1ECTS
ARLA.01.034Foetal and Neonatal Physiology and Behaviour, Breastfeeding2ECTS
ARSK.00.009Gerontology. Introduction (web-based)3ECTS
ARFA.02.126Granulation and Tableting Technology2ECTS
AROT.00.036Health Care System and Policy for Nursing Managers3ECTS
ARTH.04.018Health Promotion2ECTS
ARFA.02.138Interdisciplinary Seminars in Pharmacy2ECTS
ARAR.00.001Medical Law2ECTS
ARFA.02.134Minimally Invasive Medical Technology2ECTS
ARFS.01.005Neurophysiology of Pain2ECTS
ARFA.02.132Pharmaceutical Film and Nano-coatings2ECTS
ARFA.02.141Pharmaceutical nanotechnology4ECTS
ARFA.01.106Pharmacist in pharmacy system2ECTS
AROT.01.013Planning and Designing of Developmental Projects in Nursing3ECTS
ARTH.04.023Prevention of HIV/AIDS and HIV Positive Patient2ECTS
ARTH.04.022Principles of Sexuality Education3ECTS
ARFA.02.081Radiopharmaceuticals1ECTS
ARFA.02.145Seminars in Pharmaceutical Sciences I1ECTS
ARTH.04.024Smoking and Health1ECTS
ARFA.01.060Social Pharmacy in the Professional Literature and Internet2ECTS
ARSI.01.015Spectacles, Contact Lenses and Refractive Surgery1ECTS
ARFA.02.135Student Research in Pharmacy II6ECTS
ARFA.02.130Student Research in Pharmacy III6ECTS
ARFA.02.133Student Research in Pharmacy IV6ECTS
ARFA.02.137Student Research in Pharmacy V6ECTS
ARFA.02.015Synthesis of Active Substances2ECTS
ARSK.00.027Vaccine and Immunization Education3ECTS
ARFA.02.140Vibrational Spectroscopy- Different Applications in Pharmaceutical Drug Development1ECTS
ARTH.01.014Water and Health2ECTS
ARLA.01.033Why and to Which Factors We are Allergic?2ECTS
ARTH.01.040Work Stress and Health2ECTS
3. Pharmacy Practice (37 ECTS)
ARFA.02.071Pharmacy Practice37ECTS
4. Final Exam (5 ECTS)
ARFA.02.060Graduation Examination5ECTS
5. Optional courses (12 ECTS)

Appendix B

Table A2. The European pharmacy competences framework.
Table A2. The European pharmacy competences framework.
Domains and compenetnes
Domain 1: Personal competences—learning and knowledge
1Ability to identify learning needs and to learn independently (including continuous professional development, CPD).
2Ability to apply logic to problem solving.
3Ability to critically appraise relevant knowledge and to summarise the key points.
4Ability to evaluate scientific data in line with current scientific and technological knowledge.
5Ability to apply preclinical and clinical evidence-based medical science to pharmaceutical practice.
6Ability to apply current knowledge of relevant legislation and codes of pharmacy practice.
Domain 2: Personal competences—values
7A professional approach to tasks and human relations.
8Ability to maintain confidentiality.
9Ability to take full responsibility for patient care.
10Ability to inspire the confidence of others in one’s actions and advise.
11Knowledge of appropriate legislation and of ethics.
Domain 3: Personal competences—communication and organisational skills
12Ability to communicate effectively—both oral and written—in the locally relevant language.
13Ability to effectively use information technology.
14Ability to work effectively as part of a team.
15Ability to implement general legal requirements that impact upon the practice of pharmacy (e.g., health and safety legislation, employment law).
16Ability to contribute to the training of staff.
17Ability to manage risk and quality of service issues.
18Ability to identify the need for new services.
19Ability to understand a business environment and develop entrepreneurship.
Domain 4: Personal competences—research and industrial pharmacy
20Knowledge of design, synthesis, isolation, characterisation and biological evaluation of active substances.
21Knowledge of good manufacturing practice and of good laboratory practice.
22Knowledge of European directives on qualified persons.
23Knowledge of drug registration, licensing and marketing.
24Knowledge of the importance of research in pharmaceutical development and practice.
Domain 5: Patient care competences—patient consultation and assessment
25Ability to interpret basic medical laboratory tests.
26Ability to perform appropriate diagnostic tests e.g., measurement of blood pressure or blood sugar.
27Ability to recognise when referral to another member of the healthcare team is needed.
Domain 6: Patient care competences—need for drug treatment
28Ability to retrieve and interpret information on the patient’s clinical background.
29Ability to compile and interpret a comprehensive drug history for an individual patient.
30Ability to identify non-adherence to medicine therapy and make an appropriate intervention.
31Ability to advise to physicians on the appropriateness of prescribed medicines and—in some cases—to prescribe medication.
Domain 7: Patient care competences—drug interactions
32Ability to identify and prioritise drug-drug interactions and advise appropriate changes to medication.
33Ability to identify and prioritise drug-patient interactions, including those that prevent or require the use of a specific drug, based on pharmaco-genetics, and advise on appropriate changes to medication.
34Ability to identify and prioritise drug-disease interactions (e.g., NSAIDs in heart failure) and advise on appropriate changes to medication.
Domain 8: Patient care competences—drug dose and formulation
35Knowledge of the bio-pharmaceutical, pharmacodynamic and pharmacokinetic activity of a substance in the body.
36Ability to recommend interchangeability of drugs based on in-depth understanding and knowledge of bioequivalence, bio-similarity and therapeutic equivalence of drugs.
37Ability to undertake a critical evaluation of a prescription ensuring that it is clinically appropriate and legally valid.
38Knowledge of the supply chain of medicines thus ensuring timely flow of quality drug products to the patient.
39Ability to manufacture medicinal products that are not commercially available.
Domain 9: Patient care competences—patient education
40Ability to promote public health in collaboration with other professionals within the healthcare system.
41Ability to provide appropriate lifestyle advice to improve patient outcomes (e.g., advice on smoking, obesity, etc.).
42Ability to use pharmaceutical knowledge and provide evidence-based advice on public health issues involving medicines.
Domain 10: Patient care competences—provision of information and service
43Ability to use effective consultations to identify the patient’s need for information.
44Ability to provide accurate and appropriate information on prescription medicines.
45Ability to provide evidence-based support for patients in selection and use of non- prescription medicines.
Domain 11: Patient care competences—monitoring of drug therapy
46Ability to identify and prioritise problems in the management of medicines in a timely and effective manner and so ensure patient safety.
47Ability to monitor and report Adverse Drug Events and Adverse Drug Reactions (ADEs and ADRs) to all concerned, in a timely manner, and in accordance with current regulatory guidelines on Good Pharmacovigilance Practices (GVPs).
48Ability to undertake a critical evaluation of prescribed medicines to confirm that current clinical guidelines are appropriately applied.
49Ability to monitor patient care outcomes to optimise treatment in collaboration with the prescriber.
50Ability to contribute to the cost effectiveness of treatment by collection and analysis of data on medicines use.

References

  1. Medical Faculty, University of Tartu, Estonia. Available online: http://meditsiiniteadused.ut.ee/en (accessed on 19 December 2016).
  2. Sepp, K.; Lenbaum, K.; Laius, O.; Viidalepp, A.; Volmer, D. The “Quality guidelines for community pharmacy services”—A tool for harminozation of community pharmacy practice in Estonia. Int. J. Clin. Pharm. 2015, 10 (Suppl. 1), 33. [Google Scholar]
  3. Tallinn Healthcare College. Available online: http://www.ttk.ee/en/assistant-pharmacist-0 (accessed on 27 December 2016).
  4. Medicinal Products Act. Available online: https://www.riigiteataja.ee/en/eli/ee/525112013005/consolide/current (accessed on 27 December 2016).
  5. Directive 2005/36/EC of the European Parliament and of the Council on the recognition of professional qualifications. Off. J. Eur. Union 2005, L255, 22–142. Available online: http://eur-lex.europa.eu/legal-content/en/TXT/?uri=CELEX%3A32005L0036 (accessed on 28 March 2017).
  6. Directive 2013/55/EU of the European Parliament and of the Council amending Directive 2005/36/EC on the recognition of professional qualifications. Off. J. Eur. Union 2013, 354, 132–170. Available online: http://eur-lex.europa.eu/legal-content/EN/ALL/?uri=celex%3A32013L0055 (accessed on 28 March 2017).
  7. Medicine Study Programme Group. Self-Evaluation Report; Department of Pharmacy, University of Tartu: Tartu, Estonia, 2014. [Google Scholar]
  8. Atkinson, J.; Rombaut, B. The 2011 PHARMINE report on pharmacy and pharmacy education in the European Union. Pharm. Pract. (Internet) 2011, 9, 169–187. [Google Scholar] [CrossRef]
  9. Quality Guidelines for Community Pharmacy Services. Available online: http://www.ravimiamet.ee/sites/default/files/documents/publications/apteegiteenuse_kvaliteedijuhis_2016/apteegiteenuse_kvaliteedijuhis_2016.html#/0 (accessed on 10 December 2016).
  10. Good Hospital Pharmacy Practice. Available online: http://media.voog.com/0000/0003/1027/files/16.02.18%20-%20Eesti%20haiglafarmaatsia%20head%20tavad_Kodulehele.pdf (accessed on 10 December 2016).
  11. CoDEG (Competency Development and Evaluation Group). General Level Practice. Available online: http://www.codeg.org/frameworks/general-level-practice (accessed on 16 December 2016).
  12. Accreditation Council for Pharmacy Education. ACPE Open Forum: Accreditation Standards 2016. Available online: http://www.aacp.org/governance/SIGS/assessment/Assessment%20Docs/AACP%202014%20Interim%20Meeting%20%20presentation%20-%20ACPE%20Standards%202016.pdf (accessed on 16 December 2016).
  13. Stupans, I.; McAllister, S.; Clifford, R.; Hughes, J.; Krass, I.; March, G.; Owen, S.; Woulfeg, J. Nationwide collaborative development of learning outcomes and exemplar standards for Australian pharmacy programmes. Int. J. Pharm. Pract. 2015, 23, 283–291. [Google Scholar] [CrossRef] [PubMed]
  14. FIP/WHO. International Pharmaceutical Federation—World Health Organisation: Standards for Quality of Pharmacy Services. Available online: https://www.fip.org (accessed on 16 December 2016).
  15. Antoniou, S.; Webb, D.G.; Mcrobbie, D.; Davies, J.G.; Bates, I.P. A controlled study of the general level framework: Results of the South of England Competency Study. Pharm. Educ. 2005, 5, 201–207. [Google Scholar] [CrossRef]
  16. Coombes, I.; Avent, M.; Cardiff, L.; Bettenay, K.; Coombes, J.; Whitfield, K.; Stokes, J.; Davies, G.; Bates, I. Improvement in pharmacist’s performance facilitated by an adapted competency-based general level framework. J. Pharm. Pract. Res. 2010, 40, 111–118. [Google Scholar] [CrossRef]
  17. AFPC. Educational Outcomes for First Professional Degree Programs in Pharmacy (Entry to Practice Pharmacy Programs) in Canada. Association of Faculties of Pharmacy of Canada (AFPC): Vancouver, 2010. Available online: www.afpc.info/sites/default/files/AFPC%20Educational%20Outcomes.pdf (accessed on 16 December 16 2016).
  18. GPhC. Standards for the Initial Education and Training of Pharmacists. General Pharmaceutical Council (GPhC), 2011. Available online: www.pharmacyregulation. org/sites/default/files/GPhC_Future_Pharmacists.pdf (accessed on 16 December 2016).
  19. NCSF. National Competency Standards Framework for Pharmacists in Australia, Pharmaceutical Society for Australia (PSA), 2010. Available online: www.psa.org.au/ downloads/standards/competency-standards-complete.pdf (accessed on 16 December 2016).
  20. Atkinson, J.; Rombaut, B.; Sánchez Pozo, A.; Rekkas, D.; Veski, P.; Hirvonen, J.; Bozic, B.; Skowron, A.; Mircioiu, C.; Marcincal, A.; Wilson, K. Systems for Quality Assurance in Pharmacy Education and Training in the European Union. Pharmacy 2014, 2, 17–26. [Google Scholar] [CrossRef]
  21. Atkinson, J.; De Paepe, K.; Sánchez Pozo, A.; Rekkas, D.; Volmer, D.; Hirvonen, J.; Bozic, B.; Skowron, A.; Mircioiu, C.; Marcincal, A.; et al. The PHAR-QA Project: Competency Framework for Pharmacy Practice—First Steps, the Results of the European Network Delphi Round 1. Pharmacy 2015, 3, 307–329. [Google Scholar] [CrossRef]
  22. Atkinson, J.; De Paepe, K.; Sánchez Pozo, A.; Rekkas, D.; Volmer, D.; Hirvonen, J.; Bozic, B.; Skowron, A.; Mircioiu, C.; Marcincal, A.; et al. The Second Round of the PHAR-QA Survey of Competences for Pharmacy Practice. Pharmacy 2016, 4, 27. [Google Scholar] [CrossRef]
  23. Pharmacist Competency Framework & Domain-specific Frame of Reference for the Netherlands. Available online: https://www.knmp.nl/downloads/pharmacist-competency-frameworkandDSFR-Netherlands.pdf (accessed on 19 February 2017).
  24. Quality Assessment of the Study Programme Group Medicine at the University of Tartu, Estonia. Available online: http://ekka.archimedes.ee/wp-content/uploads/TU-meditsiin-assessment-report.pdf (accessed on 15 December 2016).
  25. Occupational Qualification Standards for Pharmacists and Assistant Pharmacists were Approved in Estonia. Available online: http://www.kutsekoda.ee/et/kutseregister/kutsestandardid/10622084 (accessed on 18 December 2016).
  26. Good Practice of Learning. Available online: http://www.tyye.ee/en/good-practice-learning (accessed on 27 December 2016).
  27. Good Practice of Teaching. Available online: http://www.ut.ee/en/search/google/good%20practice%20of%20teaching (accessed on 27 December 2016).
Figure 1. The pharmacy education and continuing professional development scheme in Estonia.
Figure 1. The pharmacy education and continuing professional development scheme in Estonia.
Pharmacy 05 00018 g001
Table 1. Comparison of seven subject areas in pharmacy programmes in EU and UT, Estonia.
Table 1. Comparison of seven subject areas in pharmacy programmes in EU and UT, Estonia.
Subject AreaProportion of Subject Areas in Pharmacy Programmes EU Main %Proportion of Subject Areas in the Pharmacy Programme (UT), Estonia %
Chemical sciences2621
Physics, mathematics64
Biological sciences112
Pharmaceutical technology1621
Medical sciences2839
Law and social sciences710
Generic subjects, traineeship63
Table 2. Distribution of subject groups within first four study years in the pharmacy programme (UT).
Table 2. Distribution of subject groups within first four study years in the pharmacy programme (UT).
Study YearDrug AnalysisPharmaceutical TechnologyMedical Sciences and Patient Care SubjectsSocial Sciences
FirstInorganic and analytical chemistry-Anatomy, physiology, medical microbiologyLatin, pharmaceutical terminology, history of pharmacy
SecondAnalytical, bioorganic and pharmaceutical chemistryPharmaceutical excipientsPhysiology, pathophysiology,
clinical microbiology, medical biochemistry, genetics, primary care medicine
Bioethics
ThirdPharmacognosy, pharmaceutical chemistryPharmaceutical technology, biotechnologyLaboratory medicine, pharmacology-
FourthMetabolism of active substancesPhysical pharmacy, biopharmacyImmunology, pharmacotherapy, first aid, drug toxicology, clinical pharmacology, clinical pharmacy,Pharmaco- epidemiology and pharmaco-economics,social pharmacy, and drug safety
Table 3. EPCF and the pharmacy programme (UT) based curriculum mapping matrix and mean values of competency levels assessed by representatives of academia and other pharmacy stakeholders.
Table 3. EPCF and the pharmacy programme (UT) based curriculum mapping matrix and mean values of competency levels assessed by representatives of academia and other pharmacy stakeholders.
Competence DomainsSpecific SubjectsSubject Area/-sFull ProgrammeMean Competency Level *, AcademiaMean Competency Level *, Other Pharmacy Stakeholders
Personal competences
1. Learning and knowledgeNA **Medical and social sciences, pharmacy internshipYes4.03.4
2. ValuesNASocial sciences, pharmacy internshipYes4.43.7
3. Communication and organizational skillsNASocial sciences, pharmacy internshipYes3.83.1
4. Research and industrial pharmacyYesPharmaceutical technology, drug analysisYes, only one competence4.02.5
Personal competence domains 1–4 mean value 4.13.2
Patient care competences
5. Patient consultation and assessmentYesMedical sciencesNA3.33.2
6. Need for drug treatmentYesMedical sciencesNA3.03.0
7. Drug interactionsYesMedical sciences, pharmaceutical technologyNA3.03.2
8. Drug dose and formulationYesPharmaceutical technology, medical sciencesNA4.23.0
9. Patient educationYesNoNA4.03.7
10. Provision of information and serviceYesMedical and social sciences, pharmaceutical technology, pharmacy internshipNA4.73.5
11. Monitoring of drug therapyYesMedical and social sciences, pharmaceutical technology, pharmacy internshipNA3.22.4
Patient care competence domains 5–11 mean value 3.63.1
* Five-point competency level evaluation scale: 1-theoretical education and 5-ability to use independently theoretical knowledge and practical skills in practice; ** NA—not applicable.

Share and Cite

MDPI and ACS Style

Volmer, D.; Sepp, K.; Veski, P.; Raal, A. The Implementation of Pharmacy Competence Teaching in Estonia. Pharmacy 2017, 5, 18. https://doi.org/10.3390/pharmacy5020018

AMA Style

Volmer D, Sepp K, Veski P, Raal A. The Implementation of Pharmacy Competence Teaching in Estonia. Pharmacy. 2017; 5(2):18. https://doi.org/10.3390/pharmacy5020018

Chicago/Turabian Style

Volmer, Daisy, Kristiina Sepp, Peep Veski, and Ain Raal. 2017. "The Implementation of Pharmacy Competence Teaching in Estonia" Pharmacy 5, no. 2: 18. https://doi.org/10.3390/pharmacy5020018

APA Style

Volmer, D., Sepp, K., Veski, P., & Raal, A. (2017). The Implementation of Pharmacy Competence Teaching in Estonia. Pharmacy, 5(2), 18. https://doi.org/10.3390/pharmacy5020018

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop